InflaRx N.V.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -96.2% | +1,476.4% | -82.4% | +1,847.8% | -100.3% | – | – | -39.6% | -242.4% | – | – | – | |
| – | +8.6% | -20.4% | +57.9% | -120.8% | – | -99.7% | +25,727.0% | -100.0% | +1,458,882.3% | -98.2% | -100.0% | – | |
| – | – | – | – | – | -1,536.7% | – | – | – | -20,921.1% | – | – | – | |
| – | +10.4% | -9.5% | +37.2% | +11.2% | -38.0% | +1.6% | +2.7% | -13.4% | -15.7% | -20.7% | +13.6% | – | |
| – | +43.9% | -14.2% | -2.2% | -19.7% | +101.9% | -10.7% | -26.9% | -29.2% | +74.0% | -30.3% | -19.8% | – | |
| – | +18.9% | -5.6% | +22.4% | +3.3% | -55.4% | +87.2% | -19.5% | -9.2% | -16.2% | -9.5% | -2.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +306.8% | -76.8% | +73.7% | -42.4% | -5.0% | -14.5% | -17.9% | +328.0% | +10.7% | -5.3% | -2.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | – | -150.0% | – | – | – | – | – | -296.1% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.